Oral Anticoagulant Drugs

Authors:
  • JOJohn A. Oates
    John A. Oates
  • AWAlastair J.J. Wood
    Alastair J.J. Wood

Abstract
The vitamin K-antagonist drugs were reviewed in the Journal in the early 1970s.1 , 2 Since then, there has been considerable progress in research at both a basic and an applied level. The mode of action of coumarins has been clarified; their role in the management of thromboembolic disorders has been more clearly defined; a system has been developed to standardize the measurement of their anticoagulant effect3; and their safety has been improved for a number of indications without compromising efficacy, through the use of a lower degree of anticoagulation than formerly in North America.4 Warfarin (a 4-hydroxycoumarin compound) is the . . .

This publication has 117 references indexed in Scilit: